Our leadership team, Board Members, and Advisors are scientists and drug developers with deep expertise in gene therapy, pain management, neurosurgical techniques, and building successful biotechnology companies.
We are applying this knowledge to build a sustainable company with an innovative and versatile gene therapy platform.
Board of Directors
Global Head of Neuroscience, Novartis Institutes for BioMedical Research; Adjunctive Professor of Neurobiology, the Stanford University School of Medicine
Principal, MPM Capital
President, Astellas Venture Management
Principal, Versant Ventures
Professor and Chair, Department of Anatomy, UCSF; Fellow of the American Academy of Arts and Sciences
Co-founder, CODA Biotherapeutics, Associate Professor, Department of Neurosurgery and Neuroscience, Emory University School of Medicine and Department of BioEngineering, Georgia Tech; Director, Gene and Cell Therapy for Neurorestoration Laboratory, Emory University
Senior Investigator, Gladstone Institutes; Professor, UCSF Departments of Medicine, Pharmacology and Ophthalmology
George Grant Hoag Professor of Chemistry and Director, Beckman Institute, California Institute of Technology
Co-founder, CODA Biotherapeutics; Professor and Emeritus Chair, Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine
President and CEO, Blade Therapeutics; Clinical Associate Professor of Anesthesia, Stanford University
Adjunct Professor of Anesthesia, Emeritus Professor of Neurology, UCSF; Scientific Director, CPMC Research Institute, Sutter Health
Executive Partner, MPM Capital; President & CEO, 28-7 Therapeutics